Does FDG PETCT have a predictive value for neoadjuvant chemotherapy response in nonmetastatic breast cancer?
PETCT SUVmax may be a factor for the predicting complete response to neoadjuvant treatment in early-stage breast cancer.
Authors
- Feyyaz Özdemir (ORCID: https://orcid.org/0000-0001-6980-2800)
- Ender Doğan (ORCID: https://orcid.org/0000-0001-8434-393X)
- Ebru GÜNDOĞAN AŞIK (ORCID: https://orcid.org/0000-0002-9910-6555)
- Seyhan Karaçavuş (ORCID: https://orcid.org/0000-0002-0651-6441)
- Şafak Yıldırım Dişli (ORCID: https://orcid.org/0000-0002-5869-0679)
Institutions
- Karadeniz Technical University (TR)
- Kayseri Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Irish Journal of Medical Science (1971 -)
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1007/s11845-024-03856-6
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00